Moderna may be able to supply as many as 3 billion doses of its coronavirus vaccine next year, announcing Thursday plans for a series of investments that it says will increase capacity at its U.S. production facilities and overseas manufacturing partners.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,